MarketInOut Stock Screener Log In | Sign Up

Albert David Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Albert David Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization4,379.39 mln
Float2.05 mln
Earnings Date11/12/2026

EPS

39.90
Exceptional

P / E

18.97
Moderately valued

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-2.6
Likely reliable

Relative Strength

55 / 100
Slightly ahead

Debt / Equity

0.08
Debt-free

Business Description

Founded in 1938 and based in Kolkata, India, Albert David Limited is a long-established pharmaceutical company that produces and sells a wide range of medical products both domestically and abroad. Its offerings span injectable treatments, oral medicines, topical applications, herbal remedies, and specialty products covering areas such as women's health, bone care, and eye care. The company also supplies raw drug ingredients to other manufacturers.

Key Fundamentals

EPS39.90
P/E18.97
ROE5.75
RPS638
ROIC5.95
ROA4.31
Interest Cover6.59
EBITDA, mln401
EV / EBITDA5.24
EV / EBIT6.90
Revenue, mln3,644
EV / Revenue0.58

Quote Details

Last 757.00
Change -8 (-1.05%)
Open 765.00
Volume 211
Turnover 159,727
Average Volume 140.67

Financial Ratios

Pre-Tax Profit Margin8
Current Ratio3.24
Price / Book1.13
Price / Tangible Book1.13
Debt / Equity0.08
Price / Sales1.21

Financial Strength

Altman Z-Score4.15
Piotroski F-Score 3 / 9
Beneish M-Score-2.6
Price to Intrinsic Value1.12
Price to Graham Number0.99
Shiller PE Ratio12.79

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.13% 47 / 100   
1 Month -13.98% 22 / 100   
2 Months 10.22% 82 / 100   
6 Months 7.31% 73 / 100   
1 Year -4.18% 68 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog